The study, led by an international team of researchers, identified mutations in RNU2-2—a small non-coding gene—as the cause of a newly characterised neurodevelopmental condition. This work represents a significant step forward in understanding the role of previously overlooked regions of the genome, particularly non-coding sequences that do not produce proteins but play critical roles in gene regulation and cellular function.
Dr Nicky Whiffin, Principal Investigator at the Centre for Human Genetics, was among the researchers contributing to this discovery. Her involvement builds on ongoing efforts within Oxford to improve the interpretation of genetic variation and to uncover the causes of rare diseases.
Alongside this study, Nicky has also contributed to new findings on RNU4-2-associated disorders, recently published in Nature and Nature Genetics. These studies further advance understanding of how variation in small non-coding genes can drive human disease, reinforcing the growing importance of this previously underexplored part of the genome.
Together, these discoveries highlight the power of genomic technologies to uncover hidden causes of disease and have important implications for patients and families. By enabling more accurate genetic diagnoses, they pave the way for improved clinical care and future therapeutic development.
The findings also underscore Oxford’s leading role in genomic medicine and collaborative research tackling complex genetic conditions.
Links to Nature and Nature Genetics papers:
Saturation editing of RNU4-2 reveals distinct dominant and recessive disorders